Literature DB >> 15227525

Aminoglycoside therapy: current and prospective uses.

J E Leggett1.   

Abstract

Entities:  

Year:  1990        PMID： 15227525      PMCID： PMC324943     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


× No keyword cloud information.
  52 in total

1.  Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections.

Authors:  J P Quinn; E J Dudek; C A DiVincenzo; D A Lucks; S A Lerner
Journal:  J Infect Dis       Date:  1986-08       Impact factor: 5.226

2.  Clinical response and peak concentrations of aminoglycosides.

Authors:  E B Rotheram
Journal:  J Infect Dis       Date:  1988-02       Impact factor: 5.226

3.  A study of amikacin given once versus twice daily in serious infections.

Authors:  R Maller; B Isaksson; L Nilsson; L Sörén
Journal:  J Antimicrob Chemother       Date:  1988-07       Impact factor: 5.790

4.  Once daily administration of netilmicin compared with thrice daily, both in combination with metronidazole, in gangrenous and perforated appendicitis.

Authors:  S T Fan; W Y Lau; C H Teoh-Chan; K F Lau; E H Mauracher
Journal:  J Antimicrob Chemother       Date:  1988-07       Impact factor: 5.790

5.  Effect of the pH and osmolality of urine on the antibacterial activity of gentamicin.

Authors:  M Papapetropoulou; J Papavassiliou; N J Legakis
Journal:  J Antimicrob Chemother       Date:  1983-12       Impact factor: 5.790

6.  Bioactivity of gentamicin in purulent sputum from patients with cystic fibrosis or bronchiectasis: comparison with activity in serum.

Authors:  J Levy; A L Smith; M A Kenny; B Ramsey; F D Schoenknecht
Journal:  J Infect Dis       Date:  1983-12       Impact factor: 5.226

Review 7.  Aminoglycoside antibiotics in clinical use.

Authors:  S J Pancoast
Journal:  Med Clin North Am       Date:  1988-05       Impact factor: 5.456

Review 8.  Aminoglycosides: current role in antimicrobial therapy.

Authors:  B A Cunha
Journal:  Pharmacotherapy       Date:  1988       Impact factor: 4.705

9.  Interaction of aminoglycoside antibiotics and calcium channel blockers at the neuromuscular junctions.

Authors:  A G Paradelis; C J Triantaphyllidis; M Mironidou; L G Crassaris; D N Karachalios; M M Giala
Journal:  Methods Find Exp Clin Pharmacol       Date:  1988-11

10.  High-level resistance to gentamicin in clinical isolates of enterococci.

Authors:  B D Mederski-Samoraj; B E Murray
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226
View more
  1 in total

1.  Correlation of the pharmacokinetic parameters of amikacin and ceftazidime.

Authors:  Duangchit Panomvana; Sam-Ang Kiatjaroensin; Danabhand Phiboonbanakit
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.